Cargando…
Serum Branch Chain Amino Acids (BCAAs) Are Elevated Due to Decreased Catabolism in Patients With Ketosis-Prone Diabetes at the Time of Presentation With DKA
Patients with “A-β+” Ketosis-Prone Diabetes (KPD) develop diabetic ketoacidosis (DKA) despite lacking islet autoantibodies and a phenotype of T1D, have good beta cell function and can come off insulin therapy 4–8 weeks after the DKA episode. When near-normoglycemic and stable on metformin, they have...
Autores principales: | Hsu, Jean Wei, Mehta, Paras Bharatesh, Kikani, Nupur, Keene, Kelly, Gaba, Ruchi, Ram, Nalini, Peacock, William F, Rasmus, Bennet, Lernmark, Ake, Jahoor, Farook, Balasubramanyam, Ashok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266157/ http://dx.doi.org/10.1210/jendso/bvab048.877 |
Ejemplares similares
-
MON-LB125 Dka From a Ketogenic Diet and Intermittent Fasting or Ketosis-Prone Diabetes?
por: Athonvarangkul, Diana, et al.
Publicado: (2020) -
MON-132 DKA Accompanied with Concomitant Hypertriglyceridemia-Induced Acute Pancreatitis as Initial Presentation of Ketosis-Prone Diabetes
por: Monsour, Elio, et al.
Publicado: (2019) -
Ketosis Prone Diabetes in an Obese Male Adolescent: A Case Report
por: Alhammad, Zahrah, et al.
Publicado: (2021) -
Pathogenesis of A(−)β(+) Ketosis-Prone Diabetes
por: Patel, Sanjeet G., et al.
Publicado: (2013) -
Selecting Patients at Risk of Developing DKA on Gliflozins
por: Maletkovic, Jelena
Publicado: (2021)